Monoclonal Antibodies: Targeted Therapy
Monoclonal Antibodies (MABs) are a type of targeted medicine remedy. These medicines honor and find specific proteins on cancer cells. There are numerous different MABs to treat cancer. They work in different ways to kill the cancer cell or stop it from growing. Monoclonal antibody remedy is a form of targeted treatment that uses lab-created antibodies that find and kill specific cancer cells. Physicians who treat cancer (oncologists) also use monoclonal antibody remedy to boost the vulnerable system’s capability to defend against cancer. Providers can use this treatment on its own or with other treatments.
Related Conference of Monoclonal Antibodies: Targeted Therapy
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Monoclonal Antibodies: Targeted Therapy Conference Speakers
Recommended Sessions
- Allergy & Therapies
- Clinical Immunology & Current & Future Research
- Cytokine based immunotherapy
- Eco Immunology & Behavioural Immunity
- Immune Disorders
- Immunity biological process
- Immuno-Dermatology
- Immuno-Genetics
- Immunoinformatics & Systems Immunology
- Immunology
- Immunomodulators & their side effects
- Molecular Immunology
- Monoclonal Antibodies: Targeted Therapy
- Mucosal Immunology
- Neonatal & Pediatric Immunology
- NeuroImmunology
- Regenerative Immunity
- Reproductive Immunology
- Role of nanomedicine in Immunotherapieutics
- T & B Cell Biology
- Transplant Immunology
- Tumor Immunology
- Infections & Disease
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)